Sana Biotechnology, Inc. (SANA)

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	83.8	71.87	127.57	133.52	176.77	253.03
Short-Term Investments	17.34	66.51	24.93	71.68	247.2	297.97
Cash & Short-Term Investments	101.14	138.38	152.5	205.2	423.96	551
Cash Growth	-3.40%	-9.26%	-25.68%	-51.60%	-23.05%	45.66%
Other Current Assets	10.55	10.29	8.31	8.32	20.47	7.11
Total Current Assets	111.69	148.68	160.81	213.52	444.44	558.1
Net Property, Plant & Equipment	61.52	65.22	135.27	145.59	159.4	161.78
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2	59.2
Goodwill	140.63	140.63	140.63	140.63	140.63	140.63
Long-Term Investments	-	-	-	-	10.05	195.88
Other Long-Term Assets	0.56	3.17	5.12	6.37	9.01	13.82
Total Assets	373.59	416.89	501.02	565.3	822.72	1,129

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.12	1.67	5.21	4.11	2.86	2.22
Accrued Expenses	15.71	21.92	27.69	47.18	40.91	31.48
Current Portion of Leases	14.88	14.94	12.53	13.2	12.39	9.16
Other Current Liabilities	53.56	40.2	-	-	55.35	56.38
Total Current Liabilities	86.27	78.73	45.43	64.49	111.5	99.24
Long-Term Leases	60.45	63.92	81.66	90.9	95.86	101.78
Other Long-Term Liabilities	107.64	113.36	123.42	122.41	116.04	199.89
Total Long-Term Liabilities	168.09	177.28	205.08	213.31	211.9	301.67
Total Liabilities	254.35	256.01	250.52	277.79	323.41	400.91

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.03	0.03	0.02	0.02	0.02	0.02
Additional Paid-in Capital	2,015	2,010	1,855	1,626	1,558	1,515
Accumulated Other Comprehensive Income	-0	0.03	0.01	-0.06	-4.33	-1.37
Retained Earnings	-1,896	-1,849	-1,605	-1,338	-1,055	-785.36
Total Common Shareholders' Equity	119.24	160.88	250.5	287.51	499.32	728.5
Shareholders' Equity	119.24	160.88	250.5	287.51	499.32	728.5
Total Liabilities & Equity	373.59	416.89	501.02	565.3	822.72	1,129

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	75.33	78.86	94.2	104.1	108.25	110.94
Net Cash (Debt)	25.81	59.52	58.3	101.1	315.71	440.05
Net Cash Growth	92.78%	2.09%	-42.33%	-67.98%	-28.26%	43.64%
Net Cash Per Share	0.10	0.23	0.25	0.52	1.68	2.64
Book Value	119.24	160.88	250.5	287.51	499.32	728.5
Book Value Per Share	0.45	0.64	1.08	1.48	2.65	4.38
Tangible Book Value	-80.58	-38.94	50.68	87.68	299.49	528.68
Tangible Book Value Per Share	-0.31	-0.15	0.22	0.45	1.59	3.18

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 11, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error